Innovation Pharmaceuticals Provides Update on Brilacidin Antiviral Research
WAKEFIELD, Mass., Aug. 02, 2021 (GLOBE NEWSWIRE) — Innovation Pharmaceuticals (OTCQB:IPIX) (the Company), a clinical stage biopharmaceutical company, today provided an update on ongoing antiviral research of Brilacidin, the Companys defensin-mimetic drug…
